Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Net Cash Flow (2019 - 2025)

Silo Pharma's Net Cash Flow history spans 7 years, with the latest figure at -$416045.0 for Q3 2025.

  • For Q3 2025, Net Cash Flow fell 217.33% year-over-year to -$416045.0; the TTM value through Sep 2025 reached -$3.0 million, down 165.16%, while the annual FY2024 figure was $381491.0, 104.86% up from the prior year.
  • Net Cash Flow for Q3 2025 was -$416045.0 at Silo Pharma, up from -$897166.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $6.1 million in Q3 2021 and bottomed at -$6.7 million in Q1 2023.
  • The 5-year median for Net Cash Flow is -$485611.0 (2021), against an average of -$216563.6.
  • The largest annual shift saw Net Cash Flow skyrocketed 3518.95% in 2021 before it tumbled 1212.59% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at -$424415.0 in 2021, then tumbled by 108.76% to -$885989.0 in 2022, then surged by 475.23% to $3.3 million in 2023, then tumbled by 128.73% to -$955091.0 in 2024, then skyrocketed by 56.44% to -$416045.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Net Cash Flow are -$416045.0 (Q3 2025), -$897166.0 (Q2 2025), and -$768919.0 (Q1 2025).